Trade Articles
OnDrug Delivery | March 2022
American Pharmaceutical Review | December 2021
Improving Preclinical Outcomes: De-Risking Your Drug Development Program
Contract Pharma | June 2021
Preparing for Preclinical Testing: A Readiness Checklist
Drug Discovery & Development | May 2021
Managing critical reagents through drug development
AAPS Journal | May 2021
Bioanalysis in the Age of New Drug Modalities
Drug Discovery & Development | April 2021
Analyzing FDA guidance on DDI studies for therapeutic proteins
Drug Discovery & Development | February 2022
5 questions drug developers need to ask when vetting laboratory testing partners
Drug Discovery & Development | December 2021
The opportunities and challenges inherent in using protein biomarkers for new drug development
Genetic Engineering and Biotechnology News | November 2021
Using In Vitro–In Vivo Extrapolation to Predict Human Clearance
Regulatory Focus | June 2021
The transition to ICH M10 and its impact on global submissions
Life Science Leader | May 2021
Improving Submission Quality: Preparing For Regulatory Differences
PharmaManufacturing | March 2021
Winning the drug development relay